异动解读 | 凯瑟琳·伍德看好AI医药 RXRX盘前大涨逾21%

异动解读
06 Feb

美股盘前交易中,RXRX(Recursion Pharmaceuticals, Inc.)一度大涨逾21%,成为焦点股。

消息面上,投资机构ARK Invest近日发布研究报告《Big Ideas 2025》,看好AI、多组学等技术在医药行业的应用前景。报告指出,AI技术有望大幅降低药物研发成本,改变制药行业的回报状况。

ARK Invest负责人凯瑟琳·伍德("木头姐")的投资组合中包括了RXRX在内的多家AI医药公司。RXRX凭借利用人工智能技术加速药物开发流程的商业模式,近期获得市场热捧,股价大涨。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10